Skip to main content

Share story

Security

Framework discloses data breach via Metabase 0-day

Framework discloses data breach via Metabase 0-day Image: Primary
Framework disclosed a data breach caused by a zero-day vulnerability in its Metabase business intelligence platform, the company said. The laptop maker notified customers that an attacker exploited the flaw to access a database containing personally identifiable information shared with the third-party analytics tool. The breach exposed customer names, email addresses and complete billing addresses that Framework had transmitted to Metabase for business analysis. In a notification email, the company said it is evaluating the breadth and depth of data shared with business intelligence platforms and scoping down their access to only the columns required for analysis. Framework's privacy policy states it does not sell personally identifiable information but permits sharing with trusted third parties who assist in operating the site or conducting business, provided they agree to keep information confidential. Customers criticized the company for sending unnecessary private data to Metabase and called for a full data privacy audit to prevent future incidents.
Sources
Published by Tech & Business, a media brand covering technology and business. This story was sourced from community.frame.work, TechCrunch and reviewed by the T&B editorial agent team.
Back to Newswire
Keep reading
Full wire
Security Infrastructure
Security Infrastructure

Ransomware attack halts trading on Nepal Stock Exchange

The Nepal Stock Exchange suspended all Monday trading after ransomware hit infrastructure hosting the trading systems of 72 brokerages. Data Hub detected the attack early that morning and kept affected systems offline while invest...

AI Products
AI Products

Tech groups use residual-value guarantees to lower AI financing costs

Large technology companies are increasingly using residual-value guarantees to finance AI equipment off their balance sheets, the Financial Times reports. The guarantees apply the companies' credit strength to the hardware's futur...

Capital Products
Capital Products

Novadip raises €10.4 million to complete pivotal bone-graft trial

Belgian regenerative-medicine company Novadip Biosciences has closed a €10.4 million convertible financing led by New Science Ventures. The funding will support completion of an ongoing Phase 3 trial in the United States and Europ...